Henlius Speeds Up Efforts On Ophthalmic Bevacizumab

Phase III Trial Begins As Chinese Firm Works With Partner Essex On Global Filings

 
• By David Wallace
Eye Data Ophthalmic
Henlius is eyeing several marketing authorization applications • Source: Sergey Nivens

More from Biosimilars

More from Products